TITLE

Diabetik Retinopatide Argon Lazer ve Dye Lazerle Yapılan Pan Retinal Fotokoagulasyon Tedavilerinin Etkinliklerinin Karşılaştırılması

AUTHOR(S)
APAYDIN, Cemil; AKAR, Yusuf; HACIOǦULLARI, Semir; ÖNER, Aslı
PUB. DATE
March 2007
SOURCE
Retina-Vitreus/Journal of Retina-Vitreous;Mar2007, Vol. 15 Issue 1, p31
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Purpose: To compare the effect of the panretinal laser photocoagulation treatments performed using argon and dye yellow lasers in diabetic retinopathy. Materials and Methods: Both eyes of 32 type 2 diabetes patients who were diagnosed as early proliferative diabetic retinopathy were included in the study. Each patient underwent panretinal laser photocoagulation treatment for a total of three sessions using argon green laser for one eye and the dye yellow laser for the fellow eye. Each eye underwent a total of 1800-2000 laser burns with a spot size of 500 microns. Complete ophthalmological examinations of each eye were performed before and 1 and 3 months following the laser treatment. Color vision and visual field analysis of the subjects were repeated 3 months after the laser treatment. Statistical analysis of the study was performed using Mann Whitney U test, Wilcoxon signed rank test and ANOVA for repeated measures. Results: There were no significant difference between both laser therapy types in terms of neovascularization regression and the visual acuity (p>0.05). No significant intergroup difference in visual field mean sensitivity were noted before (p:0.06) and after (p:0.13) the laser treatment. Pain scores were found to be significantly higher in eyes treated with dye yellow laser (p:0.001). Conclusion: There have been no significant difference between panretinal laser photocoagulation treatments performed using either dye yellow or argon green laser in terms of visual acuity and the functional visual field sensitivity. As dye yellow laser is found to be more painful, panretinal laser photocoagulation treatments using argon laser seems to be more appropriate in treatment of patients with proliferative diabetic retinopathy.
ACCESSION #
28451729

 

Related Articles

  • Advances in the Medical Treatment of Diabetic Retinopathy. Simó, Rafael; Hernández, Cristina // Diabetes Care;Aug2009, Vol. 32 Issue 8, p1556 

    The article focuses on the advances made in relation to the medical treatment of diabetic retinopathy. It notes that proliferative diabetic retinopathy (PDR) stands as the leading cause of blindness among the working-age population in developed nations while diabetic macular edema (DME) is more...

  • Retinopathy in Newly Diagnosed Type 2 Diabetics with a special stress on the importance of glycemic control. Khare, R.; Sengar, N. S. // Bangladesh Journal of Medical Science;Jan2015, Vol. 14 Issue 1, p39 

    Background: Diabetes mellitus (DM) is a major health problem with long-term microvascular and macrovascular complications responsible for the majority of its mortality and morbidity. The development and progression of diabetic complications are strongly related to the degree of glycemic control....

  • EASD 44th Annual Meeting. Siddall, Rhonda // Practice Nurse;10/10/2008, Vol. 36 Issue 6, p42 

    The article discusses two studies on diabetes presented at the 44th Annual Meeting of the European Association for the Study of Diabetes (EASD) held in Rome in September 2008. The first study demonstrated that early blood glucose lowering intervention in type 2 diabetes patients may lead to...

  • Regulatory T cells in the pathogenesis of type 2 diabetes mellitus retinopathy by miR-155. YANG, T.-T.; SONG, S.-J.; XUE, H.-B.; SHI, D.-F.; LIU, C.-M.; LIU, H. // European Review for Medical & Pharmacological Sciences;2015, Vol. 19 Issue 11, p2010 

    OBJECTIVE: To explore the regulatory T cells (Treg) in the peripheral blood of diabetic retinopathy patients by microRNA-155 (miR-155), and investigate the mechanisms of regulatory T cells and miR-155 in the pathogenesis of diabetic retinopathy. PATIENTS AND METHODS: The study explores the...

  • Quality of previous diabetes care among patients receiving services at ophthalmology hospitals in Mexico. Rodr¡guez-Saldana, Joel; Rosales-Campos, Andrea C.; Rangel Le¢n, Carmen B.; Vzquez-Rodr¡guez, Laura I.; Mart¡nez-Castro, Francisco; Piette, John D. // Revista Panamericana de Salud Publica;Dec2010, Vol. 28 Issue 6, p440 

    Objective. To survey a large sample of type 2 diabetes mellitus (T2DM) patients in Mexico City to determine if patient experience, access to basic services, treatment, and outcomes differed between those with social security coverage and those without. Methods. From 2001-2007 a total of 1 000...

  • Triamcinolone.  // Reactions Weekly;5/2/2009, Issue 1250, p38 

    The article describes the case of two male patients who acquired late glaucoma. The patient who has non-insulin-dependent diabetes mellitus developed their respective conditions after being treated with triamcinolone for diabetic retinal oedema. Glaucoma of the patients were treated with argon...

  • Acute orbital effects of retrobulbar injection on optic nerve head topography. Akar, Y.; Apaydin, K. C.; Ozel, A. // British Journal of Ophthalmology;Dec2004, Vol. 88 Issue 12, p1573 

    Aim: To assess the effects of acute orbital volume changes after retrobulbar injection on optic nerve head topography. Methods: The study population consisted of 95 patients with type 2 diabetes mellitus with clinically significant macular oedema who required focal pattern laser photocoagulation...

  • Blue clue: diabetes. Harrar, Sarí N. // Prevention;Nov2004, Vol. 56 Issue 11, p38 

    Discusses how washed-out color vision might be a warning sign of type 2 diabetes. Vision checks that revealed that 32% of people with diabetic retinopathy had trouble seeing blues and yellows; Importance of early detection.

  • Color vision and neuroretinal function in diabetes. Wolff, B.; Bearse, M.; Schneck, M.; Dhamdhere, K.; Harrison, W.; Barez, S.; Adams, A. // Documenta Ophthalmologica;Apr2015, Vol. 130 Issue 2, p131 

    Purpose: We investigate how type 2 diabetes (T2DM) and diabetic retinopathy (DR) affect color vision (CV) and mfERG implicit time (IT), whether CV and IT are correlated, and whether CV and IT abnormality classifications agree. Methods: Adams desaturated D-15 color test, mfERG, and fundus...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics